Shopping Cart
- Remove All
- Your shopping cart is currently empty
Peptide5 acetate reduces animal swelling, astrogliosis, and neuronal cell death after spinal cord injury. Peptide5 acetate significantly reduces the degree of spinal cord injury (SCI) in a rodent ex vivo model.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $117 | In Stock | |
2 mg | $165 | In Stock | |
5 mg | $262 | In Stock | |
10 mg | $388 | In Stock | |
25 mg | $592 | In Stock | |
50 mg | $828 | In Stock | |
100 mg | $1,110 | In Stock | |
200 mg | $1,480 | In Stock |
Description | Peptide5 acetate reduces animal swelling, astrogliosis, and neuronal cell death after spinal cord injury. Peptide5 acetate significantly reduces the degree of spinal cord injury (SCI) in a rodent ex vivo model. |
In vitro | Treatment with Peptide5 acetate reduced both the level of Cx43 and the number of glial fibrillary acidic protein (GFAP)-positive astrocytes, and at the same time reduces the loss of NeuN- and SMI-32–positive neurons in a concentration- and time-dependent manner. Peptide5 acetate produces a more significant reduction in swelling[2]. |
In vivo | Peptide5 acetate can be used in the treatment of traumatic spinal cord injured rats[2]. |
Relative Density. | no data available |
Storage | store at low temperature,store under nitrogen,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 50.00 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.